Related Experiment Videos
Executive dysfunction in Alzheimer disease
Margaret M Swanberg1, Rochelle E Tractenberg, Richard Mohs
1Department of Neurology, David Geffen School of Medicine at UCLA, 90095-1769, USA.
Background:
Executive dysfunction (EDF) is common in Alzheimer disease (AD); however, its relationship to other symptoms is difficult to assess in patients with AD.
Objectives:
To determine the prevalence of EDF and study its relationship to cognitive, functional, and neuropsychiatric symptoms in patients with AD.
Design, Setting, And Patients:
A retrospective analysis of data from participants in the English Instruments Protocol of the Alzheimer's Disease Cooperative Study. Subjects were drawn from a sample of patients evaluated at tertiary referral centers.
Results:
A total of 64% of AD patients were classified as having EDF. Patients with EDF performed worse on tests of cognition (P <.001), dementia severity (P <.001), and activities of daily living (P =.01) and had more frequent symptoms of psychosis (P =.03) with greater emergence during the 12-month interval (P =.03) compared with patients with normal executive function. Less than 30% of the variance in executive function performance was explained by cognitive measures.
Conclusion:
These findings support the assessment of executive function in persons with AD and the importance of frontal lobe dysfunction in AD.